Anne W M Lee Selected Research

Anne W M Lee Research Topics

Disease

52	Nasopharyngeal Carcinoma 10/2022 - 05/2002
28	Neoplasms (Cancer) 01/2022 - 07/2003
10	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2021 - 10/2005
5	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2012
3	Carcinoma (Carcinomatosis) 01/2022 - 07/2012
2	Epstein-Barr Virus Infections 01/2019 - 09/2012
2	Hearing Loss (Hearing Impairment) 01/2018 - 03/2014
2	Squamous Cell Carcinoma of Head and Neck 01/2016 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012 - 11/2011
2	AIDS-Related Complex (ARC) 01/2012 - 11/2011
2	Breast Neoplasms (Breast Cancer) 04/2008 - 07/2007
1	Hypothyroidism 03/2022
1	Hepatitis B 12/2020
1	Extranodal Extension 12/2020
1	Second Primary Neoplasms (Neoplasms, Second) 12/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Paralysis (Palsy) 01/2019
1	Hypoglossal Nerve Diseases 01/2019
1	Stomatognathic Diseases (Dental Disease) 12/2018
1	Atherosclerosis 01/2018
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2018
1	Epistaxis (Nosebleed) 01/2018
1	Necrosis 01/2017
1	Disease Progression 04/2015
1	Neutropenia 04/2015
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2013
1	Lung Neoplasms (Lung Cancer) 10/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2012
1	Liver Neoplasms (Liver Cancer) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Arthrogryposis renal dysfunction cholestasis syndrome 11/2011
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011
1	Margins of Excision 03/2011
1	Sensorineural Hearing Loss 04/2009
1	Deafness (Deaf Mutism) 03/2009

Drug/Important Bio-Agent (IBA)

10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2010
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 08/2005
4	Capecitabine (Xeloda)FDA Link 01/2022 - 07/2011
4	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2010
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 07/2012
2	Biological ProductsIBA 01/2018 - 01/2017
1	B7-H1 AntigenIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Cetuximab (Erbitux)FDA Link 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2016
1	Pharmaceutical PreparationsIBA 10/2015
1	ElectrolytesIBA 04/2015
1	2-MethoxyestradiolIBA 12/2012
1	Environmental CarcinogensIBA 09/2012
1	Ethiodized Oil (Ethiodol)FDA Link 01/2012
1	XELOXIBA 07/2011
1	Leucovorin (Folinic Acid)FDA Link 07/2011
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2011
1	Proteins (Proteins, Gene)FDA Link 04/2011
1	human ERBB2 proteinIBA 04/2008
1	antineoplaston A10 (A 10)IBA 04/2006

Therapy/Procedure

48	Radiotherapy 03/2022 - 05/2002
19	Drug Therapy (Chemotherapy) 10/2022 - 10/2005
14	Chemoradiotherapy 01/2022 - 10/2005
12	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2020 - 02/2011
8	Adjuvant Chemotherapy 01/2022 - 08/2010
6	Therapeutics 01/2018 - 04/2011
5	Induction Chemotherapy 01/2022 - 05/2008
5	Re-Irradiation 01/2021 - 01/2015
5	Conformal Radiotherapy 01/2012 - 05/2004
1	Terminal Care (Care, Terminal) 11/2020
1	Palliative Care (Palliative Therapy) 11/2020
1	Immunotherapy 01/2019
1	Adjuvant Chemoradiotherapy 11/2017
1	Combination Drug Therapy (Combination Chemotherapy) 12/2015
1	Aftercare (After-Treatment) 04/2009
1	Segmental Mastectomy (Lumpectomy) 07/2007
1	Salvage Therapy 05/2005